Courtwright AM, Diamond JM, Sandorfi N, Goldberg HJ. The Impact of Donor-Recipient Human Leukocyte Antigen Matching on Bronchiolitis Obliterans-Free Survival Among Lung Transplant Recipients With Connective Tissue Diseases. , Clin Transplant., 38((8)): 2024

Luebker S, Frech T, Assassi S, Skaug B, Gordon JK, Lakin K, Bernstein EJ, Luo Y, Steen VD, Shah AA, Hummers LK, Richardson C, Moore DF, Khanna D, Castelino FV, Chung L, Kapoor P, Hant FN, Shanmugam VK, VanBuren JM, Alvey J, Harding M, Shah A, Makol A, Lebiedz-Odrobina D, Thomas JK, Volkmann ER, Molitor JA, Sandorfi N CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization , Rheumatology (Oxford), 20:kead176: 2023

Spiera R, Kuwana M, Khanna D, Hummers L, Frech TM, Stevens W, Matucci-Cerinic M, Kafaja S, Distler O, Jun JB, Levy Y, Leszcyzński P, Gordon J, Steen V, Lee EB, Jankowski T, Litinsky I, Chung L, Hsu V, Mayes M, Sandorfi N, Simms RW, Finzel S, de Vries-Bouwstra J, Constantine S, Dgetluck N, Dinh Q, Bloom BJ, Furst DE, White B, Denton CP; RESOLVE-1 Study Group Efficacy and Safety of Lenabasum, a Cannabinoid Type 2 Receptor Agonist, in a Phase 3 Randomized Trial in Diffuse Cutaneous Systemic Sclerosis , Arthritis Rheumatol., 75((9)): 2023

Morrisroe K, Sandorfi N, Barron M Health Care Utilization: What Is the Cost of Caring for Scleroderma? , Rheum Dis Clin North Am., 49((2)): 2023 ,359-375

Luebker S, Frech TM, Assassi S, Gordon JK, Bernstein EJ, Steen VD, Shah AA, Hummers LK, Richardson C, Khanna D, Castelino FV, Chung L, Hant FN, Shanmugam VK, VanBuren JM, Alvey J, Harding M, Sandorfi N. The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation. , Clin Exp Rheumatol. , 41((8)): 2023

Bernstein EJ, Assassi S, Castelino FV, Chung L, Correia C, Evnin LB, Frech TM, Gordon JK, Skaug BA, Hant FN, Hummers LK, Sandorfi N, Shah AA, Shanmugam VK, Steen VD, Khanna D. Computed Tomography of the Chest to Screen for Interstitial Lung Disease in Patients With Systemic Sclerosis at Expert Scleroderma Centers in the United States , ACR Open Rheumatol. : 2022

Castelino FV, VanBuren JM, Startup E, Assassi S, Bernstein EJ, Chung L, Correia C, Evnin LB, Frech TM, Gordon JK, Hant FN, Hummers LK, Khanna D, Sandorfi N, Shah AA, Shanmugam VK, Steen V. Baseline characteristics of systemic sclerosis patients with restrictive lung disease in a multi-center US-based longitudinal registry , Int J Rheum Dis. , 25(2): 2022,163-174

Luebker S, Frech T, Assassi A, Gordon J, Bernstein E, Steen V, Shah A, Hummers L, Richardson C, Khanna D, Castelino F, Chung L, Hant F, Shanmugam V, VanBuren J, Alvey J, Harding M, Evnin L, Sandorfi N The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Medication Use on Gastrointestinal Tract Symptoms in Early Disease , American College of Rheumatology Convergence Meeting: 2022

Luebker S, Frech T, Assassi A, Gordon J, Bernstein E, Steen V, Shah A, Hummers L, Richardson C, Khanna D, Castelino F, Chung L, Hant F, Shanmugam V, VanBuren J, Alvey J, Harding M, Evnin L, Sandorfi N The Collaborative National Quality and Efficacy Registry for Scleroderma: Association of Resource Utilization and Gastrointestinal Tract Symptoms in Early Disease , American College of Rheumatology Convergence Meeting: 2022

Bosso A, Assassi S, Frech T, Gordon J, Bernstein E, Richardson C, Sandorfi N, Hummers L, Shah A, Khanna D, Chung L, Castelino1 F, Hant F, Shanmugam V, VanBuren J, Larkin A, Evnin L, Steen V Autoantibodies in Patients with Early Systemic Sclerosis in the Collaborative National Quality and Efficacy Registry , American College of Rheumatology Convergence Meeting: 2022